HeartSciences Expands its Scientific Advisory Board
12 févr. 2024 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Appoints New Scientific Advisory Board Member
01 févr. 2024 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
18 janv. 2024 08h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
03 janv. 2024 16h15 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), would like to remind its shareholders to...
HeartSciences Reports Second Quarter Fiscal 2024 Financial Results
14 déc. 2023 16h15 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway
05 déc. 2023 08h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
20 nov. 2023 08h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers
13 nov. 2023 08h45 HE
|
Heart Test Laboratories, Inc.
Southlake, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology...
HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio
26 sept. 2023 08h00 HE
|
Heart Test Laboratories, Inc.
Southlake, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology...
HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.
25 sept. 2023 08h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...